JARDIANCE
Empagliflozin
- Strength
- 10 mg/1
- Form
- Tablet, Film Coated
- Class
- Sodium-Glucose Cotransporter 2 Inhibitor
A-S Medication Solutions
empagliflozin and metformin hydrochloride
Listed by Boehringer Ingelheim Pharmaceuticals, Inc.
This is a combination product. It is not interchangeable with a single-ingredient medicine containing only one of these.
| Dosage form | Tablet |
|---|---|
| Route | Oral |
| Drug class | Biguanide; Sodium-Glucose Cotransporter 2 Inhibitor |
| Approval route | NDA — original brand approval |
| NDC code | 0597-0168 |
| FDA application | NDA206111 |
| RxNorm concept | 1664315 |
| Package sizes listed | 3 |
| Marketed since | August 2015 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Empagliflozin
A-S Medication Solutions
Empagliflozin
Cardinal Health 107, LLC
Empagliflozin
A-S Medication Solutions
Empagliflozin
Aphena Pharma Solutions - Tennessee, LLC
Empagliflozin
A-S Medication Solutions
Empagliflozin
Cardinal Health 107, LLC
Empagliflozin
Boehringer Ingelheim Pharmaceuticals, Inc.
Empagliflozin
Boehringer Ingelheim Pharmaceuticals, Inc.
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.